Last reviewed · How we verify
NCT05689190
Non-invasive Flow Measurements in Patients With Lower Extremity Arterial Disease (LEAD)
trial in Lower Extremity Arterial Disease in 30 participants. Currently enrolling.
31 March 2026
Quick facts
| Lead sponsor | Philips Clinical & Medical Affairs Global |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 25 April 2023 |
| Primary completion | 31 March 2026 |
| Estimated completion | 31 March 2026 |
| Sites | 1 location across Netherlands |
Conditions studied
- Lower Extremity Arterial Disease — all drugs for Lower Extremity Arterial Disease →
Sponsor
Philips Clinical & Medical Affairs Global — full company profile →
Who can join
18 and older, any sex, with Lower Extremity Arterial Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This concerns a study with patients who will undergo endovascular treatment. Blood flow will be measured by 2D Duplex Ultrasound. Contrast data will be collected that will be processed offline.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05689190
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Philips Clinical & Medical Affairs Global trials
Trials by the same sponsor.
- NCT07521735 — NEXT GEN - PHILIPS OPTIMUS · recruiting
- NCT07368036 — MR 7700 Multinuclear Application Clinical Trial · NA · not yet recruiting
- NCT07449715 — Respiration From Pleth Validation · recruiting
- NCT07317479 — Clinical Study for P-MAR · not yet recruiting
- NCT07317427 — Precise Image for Interventional CT · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05689190 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Philips Clinical & Medical Affairs Global
- Last refreshed: 25 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05689190.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing